BIOX — BIOCERES CROP SOLUTIONS CORP
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying BIOX?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their BIOX position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime).
- +1 tracked investor added or increased positions last quarter (Ken Griffin)
- +1 tracked investors reported holding BIOX at their latest filing
- +Macro Health is 55/100 in a Squeeze regime — historically acceptable for this sectorsource
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/20/2026.
About BIOCERES CROP SOLUTIONS CORP (BIOX)
BIOCERES CROP SOLUTIONS CORP (BIOX) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Paul Tudor Jones (Tudor Investment Corp), valued at $2M. Across recent filings, tracked investors recorded 5 new positions, 4 increased, 1 reduced, and 4 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BIOX
How many top investors track BIOX
Only 1 tracked investor report this position.
BIOX Ownership Composition
How BIOCERES CROP SOLUTIONS CORP is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting BIOX
3 tracked investors have since exited this position — listed separately below.
- Ken GriffinJun 30, 2026Citadel AdvisorsShares181.1KValue$63.4K% Portfolio0.00%
Previously held BIOX
These investors reported BIOX in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Paul Tudor Jones | Tudor Investment Corp | 220.5K | $288.9K | Dec 31, 2025 |
| Izzy Englander | Millennium Management | 30.2K | $238.1K | Sep 30, 2024 |
| Steve Cohen | Point72 Asset Management | 14K | $18.4K | Dec 31, 2025 |
Recent activity
- $238.1KNov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- Increased$643.6K(486.99%)Nov 14, 2024
- Reduced$601.5K(-13.44%)May 15, 2025
- Increased$590.9K(0.33%)Aug 14, 2025
- Sold$0(-100.00%)Nov 14, 2025
- Increased$63.4K(1421.85%)Aug 14, 2026
- New$18.4KFeb 17, 2026
- Sold$0(-100.00%)May 15, 2026
- $790.9KNov 14, 2024
- Unchanged$611K(0.00%)Feb 14, 2025
- Unchanged$458.8K(0.00%)May 15, 2025
- Unchanged$449.2K(0.00%)Aug 14, 2025
- Increased$310.9K(119.40%)Dec 9, 2025
- Sold$0(-100.00%)May 15, 2026
- New$156.2KAug 14, 2024
- $858.6KMay 15, 2024
Frequently asked questions
- How many institutional investors hold BIOX?
- 1 tracked institutional investor disclosed a position in BIOX (BIOCERES CROP SOLUTIONS CORP) in their most recent 13F filing.
- Who is the largest institutional holder of BIOX?
- Paul Tudor Jones, Tudor Investment Corp, holds the largest disclosed position in BIOX, valued at $2M.
- Did institutional ownership of BIOX increase or decrease?
- Across recent 13F filings, tracked investors recorded 5 new positions, 4 increased, 1 reduced, and 4 fully exited BIOX.
- Where does this BIOX ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.